Intellinetics (INLX) Form 4: 4,500 Option Grant to Board Member

Rhea-AI Filing Summary

Form 4 overview: On 06/21/2025, Intellinetics, Inc. (ticker: INLX) granted Director John C. Guttilla a non-qualified stock option for 4,500 shares of common stock at an exercise price of $12.88 per share. The option is immediately exercisable and expires on 06/20/2035.

Following the grant, Guttilla now beneficially owns 10,500 derivative securities (stock options) in total. The grant was made under the company’s 2023 Non-Employee Director Compensation Plan as payment for board service; no open-market purchase or sale of common shares was reported.

Key implications for investors:

• The transaction increases insider exposure but involves derivative—not cash—ownership, so direct capital outlay by the director is minimal.
• The option strike of $12.88 sets a performance hurdle; value is realized only if INLX trades above this level before 06/20/2035.
• Dilution impact is de-minimis—4,500 shares represent a small fraction of INLX’s outstanding share count (exact percentage not disclosed in the filing).

No other equity transactions, sales, or purchases were disclosed.

Positive

• Director’s equity incentive aligns board member interests with shareholders through 4,500 newly granted options.

Negative

• Minor potential dilution from 4,500 additional shares if options are exercised; impact likely negligible.

Insights

Financial Analyst

TL;DR – Routine option grant; neutral impact, slight alignment benefit.

The filing shows a standard non-cash compensation grant—4,500 options at $12.88—to Director John C. Guttilla. Immediate exercisability and a 10-year term mirror typical board packages. Because there is no direct share purchase, insider sentiment signals are muted. The strike price sets upside participation while limiting downside. Dilution from 4,500 potential shares is immaterial relative to most micro-cap floats. Overall, the event is governance-related, not operational, so I classify it as neutral for valuation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Guttilla John C

(Last) (First) (Middle)

PARK 80 WEST, PLAZA ONE;

250 PEHLE AVENUE, SUITE 601

(Street)

SADDLE BROOK, NJ 07663

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTELLINETICS, INC. [ INLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option	$12.88	06/21/2025		A		4,500		06/21/2025	06/20/2035	Common Stock	4,500	(1)	10,500	D

Explanation of Responses:

1. Granted in exchange for director services to the Company, in accordance with the Company's 2023 Non-Employee Director Compensation Plan.

	/s/ John C Guttilla	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did INLX disclose in the latest Form 4?

INLX granted Director John C. Guttilla 4,500 non-qualified stock options at a $12.88 strike on 06/21/2025.

Does the filing involve any purchase or sale of INLX common stock?

No, the Form 4 only reports an option grant; no direct share transactions were reported.

What is the exercise price and term of the new options?

The options are exercisable at $12.88 per share and expire on 06/20/2035.

How many INLX derivative securities does the director now own?

After the grant, John C. Guttilla beneficially owns 10,500 stock options.

Why were the options granted?

They were issued as compensation under the company’s 2023 Non-Employee Director Compensation Plan.